Heart health

Devices and treatments for heart disease: replacement valves, rhythm devices, stents.

Listed when at least half of its revenue is in this cause

Puts its listed companies on your watchlist. Needs a free account.

BelowBase caseAbove

The one valued company trades above its base case. On StockValuer’s numbers, today’s price already pays for more than the base case expects. A good cause doesn’t make any price a good price.

Listed companies1

At least half of revenue in this cause. Sorted by how much.

Edwards LifesciencesEW · NYSE

Revenue in heart health

100%
  • Transcatheter Aortic Valve Replacement (TAVR) (counted)74%
  • Transcatheter Mitral and Tricuspid Therapies (TMTT) (counted)9%
  • Surgical Structural Heart (counted)17%

Price against value

No margin of safety
$101.85
price, off scale
$61.20
base IV/share
Bear $38.90Bull $84.86

Price 66% above base case · price Friday 20th November 2026

Also involved1

10% to 49% of revenue in this cause.

How a company gets into a cause

Listed when at least half of its revenue is in this cause, by the revenue lines in its latest 10-K. A name, a mission or a logo never counts. How causes work

What owning a share does

Buying a share on an exchange pays the seller, not the company. What you get is a part of the business and a vote at its annual meeting.

StockValuer is an educational analysis tool. Every reader sees the same causes, companies and figures. Nothing here is a recommendation to buy, sell or hold any security, or a judgement that a company does good.